Cefaseptin 75 mg Tablets for Dogs and Cats

None.

Special precautions for use in animals
The need for systemic antibiotics compared with non-antibiotic alternatives for the
treatment of superficial pyoderma should be carefully considered by the responsible
veterinarian.
As with other antibiotics which are excreted mainly by the kidneys, systemic
accumulation may occur in the body when renal function is impaired. In case of
known renal insufficiency, the dose should be reduced and antimicrobials known to
be nephrotoxic should not be administered concurrently.
This product should not be used to treat puppies or kittens of less than 1 kg of
bodyweight and kittens less than 10 weeks of age.
Use of the product should be based on susceptibility testing of the bacteria isolated
from the animal. If this is not possible, therapy should be based on local (regional,
farm level) epidemiological information about the susceptibility of the target bacteria.
Use of the product deviating from the instructions given in the SPC may increase the
prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of
treatment with other cephalosporins and penicillins, due to the potential for cross-
resistance.
Official, national and regional antimicrobial policies should be taken into account
when the product is used.
Pseudomonas aeruginosa is known for intrinsic (or natural) resistance to cefalexin.
The tablets are flavoured (presence of porcine liver powder). In order to avoid
accidental ingestion, store tablets out of reach of the animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Penicillins and cephalosporins may cause hypersensitivity (allergy) following
injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead
to cross-reactions to cephalosporin and vice versa. Allergic reactions to these
substances may occasionally be serious.
1.Do not handle this product if you know you are sensitised or if you have been
advised not to work with such preparations.
2.Handle this product with great care to avoid exposure, taking all recommended
precautions. Wash hands after use.
3. If you develop symptoms following exposure such as skin rash, you should
seek medical advice and show the package leaflet or the label to the

Revised: November 2025
MA split from NI Expiry following AN: 02308/2025Page 3 of 8
physician. Swelling of the face, lips or eyes or difficulty in breathing are more-
serious symptoms and require urgent medical attention.